Dir
Robert Mittendorff, M.D., M.B.A. is a General Partner and Global Head of Healthcare at B Capital, where he leads venture and growth investments in healthcare companies, including board roles at Carlsmed, Inc. (CARL), CapitalRx, Nalu Medical, Lively, Triumvira, Atomwise, and Carrick.[[1]](https://carlsmed.com/company/)[[2]](https://b.capital/team/robert-mittendorff/)[[3]](https://www.volastratx.com/our-team/robert-mittendorff-m-d-mba/) At Carlsmed, he serves as a Director on the Board of Directors, contributing to the Compensation Committee and Nominating and Corporate Governance Committee.[[1]](https://carlsmed.com/company/) Previously, he spent nearly a decade at Norwest Venture Partners as Partner and Co-Head of Healthcare, involved in investments and exits exceeding $10 billion in value, and held executive roles at Hansen Medical, launching robotic systems and leading partnerships with major firms like GE and Siemens.[[2]](https://b.capital/team/robert-mittendorff/)[[4]](https://triumvira.com/?team=robert-mittendorff-md)
A board-certified emergency physician trained at Stanford University after earning his M.D. from Harvard Medical School, Dr. Mittendorff also holds an M.B.A. from Harvard Business School, a B.S. in biomedical engineering from Johns Hopkins University (with honors), and has completed fellowships at Howard Hughes, MIT, and HBS.[[2]](https://b.capital/team/robert-mittendorff/)[[5]](https://growthcapadvisory.com/leading-multi-stage-healthcare-investor-b-capitals-dr-robert-mittendorff/) His career spans portfolio strategy at Merck, management consulting at BCG, clinical services at Kaiser Permanente, and extensive board experience with companies like Silk Road Medical, iRhythm Technologies, Impel NeuroPharma, and Talkspace.[[1]](https://carlsmed.com/company/)[[2]](https://b.capital/team/robert-mittendorff/)[[3]](https://www.volastratx.com/our-team/robert-mittendorff-m-d-mba/)
View full insider profile →
